Xiong Zhang

Xiong Zhang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2016 in Scientific Reports
Verified
Journal Article
Open access
JWJian-Yong Wang
Jian-Yong Wang
QZQing-Qing Zhuang
Qing-Qing Zhuang
LZLan-Bing Zhu
Lan-Bing Zhu
HZHui Zhu
Hui Zhu
TLTing Li
Ting Li
JZJian-Hong Zhu
Jian-Hong Zhu
Brain iron levels in patients of Parkinson’s disease (PD) are usually measured in postmortem samples or by MRI imaging including R2* and SWI. In this study we performed a meta-analysis to understand PD-associated iron changes in various brain regions, and to evaluate the accuracy of MRI detections comparing with postmortem results. Databases including Medline, Web of Science, CENTRAL and Embase were searched up to 19th November 2015. Ten brain regions were identified for analysis based on data extracted from thirty-three-articles. An increase in iron levels in substantia nigra of PD patients by postmortem, R2* or SWI measurements was observed. The postmortem and SWI measurements also suggested significant iron accumulation in putamen. Increased iron deposition was found in red nucleus as determined by both R2* and SWI, whereas no data were available in postmortem samples. Based on SWI, iron levels were increased significantly in the nucleus caudatus and globus pallidus. Of note, the analysis might be biased towards advanced disease and that the precise stage at which regions become involved could not be ascertained. Our analysis provides an overview of iron deposition in multiple brain regions of PD patients, and a comparison of outcomes from different methods detecting levels of iron.

10 December 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HZHai-Wen Zhao
Hai-Wen Zhao
JLJie Lin
Jie Lin
XWXue-Bao Wang
Xue-Bao Wang
XCXing Cheng
Xing Cheng
JWJian-Yong Wang
Jian-Yong Wang
JZJian-Hong Zhu
Jian-Hong Zhu
Trace elements have been recognized to play an important role in the development of Parkinson’s disease (PD). However, it is difficult to precisely identify the relationship between these elements and the progression of PD because of an insufficient number of patients. In this study, quantifications of selenium (Se), copper (Cu), iron (Fe) and zinc (Zn) by atomic absorption spectrophotometry were performed in plasma from 238 PD patients and 302 controls recruited from eastern China, which is so far the largest cohort of PD patients and controls for measuring plasma levels of these elements. We found that plasma Se and Fe concentrations were significantly increased whereas Cu and Zn concentrations decreased in PD patients as compared with controls. Meanwhile, these four elements displayed differential changes with regard to age. Linear and logistic regression analyses revealed that both Fe and Zn were negatively correlated with age in PD patients. Association analysis suggests that lower plasma Se and Fe levels may reduce the risk for PD, whereas lower plasma Zn is probably a PD risk factor. Finally, a model was generated to predict PD patients based on the plasma concentrations of these four trace elements as well as other features such as sex and age, which achieved an accuracy of 80.97±1.34% using 10-fold cross-validation. In summary, our data provide new insights into the roles of Se, Cu, Fe and Zn in PD progression.

12 March 2014 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
RLRong-Pei Liu
Rong-Pei Liu
MZMing Zou
Ming Zou
JWJian-Yong Wang
Jian-Yong Wang
JZJuan-Juan Zhu
Juan-Juan Zhu
JLJun-Mei Lai
Jun-Mei Lai
JZJian-Hong Zhu
Jian-Hong Zhu
Paroxetine, a selective serotonin reuptake inhibitor for counteracting depression, has been recently suggested as having a role in prevention of dopaminergic neuronal degeneration in substantia nigra, a hallmark of Parkinson’s disease (PD). The pathogenesis of this type of neurological disorders often involves the activation of microglia and associated inflammatory processes. Thus in this study we aimed to understand the role of paroxetine in microglia activation and to elucidate the underlying mechanism(s).

21 December 2020 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
LCLei Cui
Lei Cui
NHNa-Na Hou
Na-Na Hou
HWHong-Mei Wu
Hong-Mei Wu
XZXiang Zuo
Xiang Zuo
YLYi-Zhi Lian
Yi-Zhi Lian
JZJian-Hong Zhu
Jian-Hong Zhu
Background: Alzheimer's disease (AD) and Parkinson's disease (PD) are two major neurodegenerative diseases worldwide. Demographic aging is in rapid progress in China. Up-to-date estimates of AD and PD prevalence have not been provided.Methods: Studies that reported the prevalence of AD and PD in China were identified via a systematic database search from 1985 to 2018. Meta-analysis, local polynomial regression and autoregressive integrated moving average model were used for analyses.Results: A total of 99 studies were included in the study with populations of 385,312 and 227,228, respectively for AD and PD. The overall prevalence of AD and PD following age standardization was 3.20% [95% confidence interval (CI) = 3.17–3.23] and 1.06% (95% CI = 1.02–1.10), respectively in individuals over 60 years old. The rates increased drastically for every 10-years increment of age. The yearly prevalence of AD was predicted to increase from 3.81 to 6.17% in the next 5 years. Significant differences were observed between genders [male to female odds ratio (OR) for AD = 0.57, 95% CI = 0.51–0.64; OR for PD = 1.25, 95% CI = 1.06–1.46], and between education levels (Illiterate to non-illiterate OR for AD = 2.99, 95% CI = 2.38–3.75), but not between urban and rural settings.Conclusion: Our results provide an updated insight into the epidemiology of AD and PD in China and their associated rates and ratios. The findings may facilitate China policy makers and health professionals mitigate the related health issues.

1 September 2017 in International Immunopharmacology
Verified
Journal Article
Closed access
HFHui-Hui Fan
Hui-Hui Fan
LZLan-Bing Zhu
Lan-Bing Zhu
TLTing Li
Ting Li
HZHui Zhu
Hui Zhu
YWYa-Nan Wang
Ya-Nan Wang
XZXiong Zhang
Xiong Zhang

22 January 2021 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
HZHong-Qiu Zhang
Hong-Qiu Zhang
JWJian-Yong Wang
Jian-Yong Wang
ZLZhao-Feng Li
Zhao-Feng Li
LCLei Cui
Lei Cui
SHShi-Shi Huang
Shi-Shi Huang
JZJian-Hong Zhu
Jian-Hong Zhu